{
  "symbol": "BBIO",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap tech", "speculative retail interest"],
    "riskScore": 7,
    "reason": "BridgeBio Pharma operates in the biotechnology sector, which is prone to hype and speculation, especially with its focus on genetic diseases and clinical trials. The company's small-cap nature and presence in speculative retail circles increase its susceptibility to social media-driven volatility."
  }
}